As of 2025-03-21, the EV/EBITDA ratio of OptiBiotix Health PLC (OPTI.L) is -11.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OPTI.L's latest enterprise value is 17.84 mil GBP. OPTI.L's TTM EBITDA according to its financial statements is -1.56 mil GBP. Dividing these 2 quantities gives us the above OPTI.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 12.4x | 9.3x |
| Forward P/E multiples | 10.4x - 14.8x | 12.1x |
| Fair Price | (15.34) - (18.53) | (15.79) |
| Upside | -178.7% - -195.0% | -181.0% |
| Date | EV/EBITDA |
| 2025-03-19 | -11.41 |
| 2025-03-18 | -10.94 |
| 2025-03-17 | -10.00 |
| 2025-03-14 | -10.00 |
| 2025-03-13 | -10.00 |
| 2025-03-12 | -10.00 |
| 2025-03-11 | -10.00 |
| 2025-03-10 | -10.47 |
| 2025-03-07 | -10.78 |
| 2025-03-06 | -10.78 |
| 2025-03-05 | -10.78 |
| 2025-03-04 | -10.78 |
| 2025-03-03 | -10.78 |
| 2025-02-28 | -10.63 |
| 2025-02-27 | -10.47 |
| 2025-02-26 | -10.63 |
| 2025-02-25 | -10.63 |
| 2025-02-24 | -10.63 |
| 2025-02-21 | -10.16 |
| 2025-02-20 | -10.16 |
| 2025-02-19 | -10.16 |
| 2025-02-18 | -9.22 |
| 2025-02-17 | -8.75 |
| 2025-02-14 | -8.75 |
| 2025-02-13 | -8.75 |
| 2025-02-12 | -8.75 |
| 2025-02-11 | -9.06 |
| 2025-02-10 | -9.06 |
| 2025-02-07 | -9.06 |
| 2025-02-06 | -9.06 |
| 2025-02-05 | -9.06 |
| 2025-02-04 | -9.22 |
| 2025-02-03 | -9.14 |
| 2025-01-31 | -9.53 |
| 2025-01-30 | -9.53 |
| 2025-01-29 | -9.53 |
| 2025-01-28 | -9.53 |
| 2025-01-27 | -9.22 |
| 2025-01-24 | -10.00 |
| 2025-01-23 | -10.16 |
| 2025-01-22 | -10.47 |
| 2025-01-21 | -10.47 |
| 2025-01-20 | -10.47 |
| 2025-01-17 | -9.84 |
| 2025-01-16 | -9.61 |
| 2025-01-15 | -9.84 |
| 2025-01-14 | -10.16 |
| 2025-01-13 | -10.16 |
| 2025-01-10 | -10.16 |
| 2025-01-09 | -10.16 |